MiNK Therapeutics, Inc. Shares Issued
MiNK Therapeutics, Inc. (INKT) had Shares Issued of 5.10 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares, Issued 5.10M shares.
- 2026-03-31: Common Stock, Shares, Issued 4.97M shares.
- 2025-12-31: Common Stock, Shares, Issued 4.71M shares.
- 2025-09-30: Common Stock, Shares, Issued 4.60M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 5.10M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 4.97M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 4.71M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 4.60M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 3.99M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 3.97M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 3.96M shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 39.55M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 39.45M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 34.70M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 3.46M shares 10-K · filed 2025-03-18 | 34.60M shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 34.52M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 34.46M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 34.30M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 33.86M shares 10-K · filed 2024-03-21 | |
| 2022-09-30 | 33.79M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 33.67M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 33.56M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 33.48M shares 10-K · filed 2023-03-24 | |
| 2021-09-30 | 24.22M shares 10-Q · filed 2021-11-29 | |
| 2020-12-31 | 24.18M shares 10-K · filed 2022-03-18 | 24.18M shares 10-Q · filed 2021-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |